OMKPQRALALZYMT-UHFFFAOYSA-N
C20H14BrF3N4O3 — CID 155730245
Data last refreshed: (MolForge compound catalog, from PubChem)
About OMKPQRALALZYMT-UHFFFAOYSA-N
OMKPQRALALZYMT-UHFFFAOYSA-N (PubChem CID 155730245) has the molecular formula C20H14BrF3N4O3 and a molecular weight of 495.26 g/mol. Its IUPAC name is 7-bromo-4,4-dimethyl-2-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]isoquinoline-1,3-dione.
Molecular Properties
| Compound Name | OMKPQRALALZYMT-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 155730245 |
| Molecular Formula | C20H14BrF3N4O3 |
| Molecular Weight | 495.26 g/mol |
| Exact Mass | 494.02 |
| IUPAC Name | 7-bromo-4,4-dimethyl-2-[[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]methyl]isoquinoline-1,3-dione |
| SMILES | CC1(C)C(=O)N(Cc2ccc(-c3nnc(C(F)(F)F)o3)cn2)C(=O)c2cc(Br)ccc21 |
| InChI | InChI=1S/C20H14BrF3N4O3/c1-19(2)14-6-4-11(21)7-13(14)16(29)28(18(19)30)9-12-5-3-10(8-25-12)15-26-27-17(31-15)20(22,23)24/h3-8H,9H2,1-2H3 |
| InChIKey | OMKPQRALALZYMT-UHFFFAOYSA-N |
| XLogP | 4.37 |
| TPSA | 89.19 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 495.26 |
| LogP ≤ 5 | 4.37 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155730245 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.